论文部分内容阅读
目的探讨病毒性脑炎采用依达拉奉注射液治疗的临床效果并进行分析评价。方法 60例患有病毒性脑炎的患者,随机分为观察组和对照组,各30例,对照组使用常规治疗方法 ,阿昔洛韦抗病毒及对症治疗(如脱水降颅压、激素、退热等治疗),观察组在对照组的基础上给予依达拉奉注射液,比较两种方法的临床治疗效果,并进行分析评价。结果对照组治疗的总有效率为80.0%;观察组治疗的总有效率为93.3%,观察组的总有效率显著高于对照组,差异具有统计学意义(P<0.05)。结论本次研究提出依达拉奉注射液治疗病毒性脑炎,可有效提高患者治愈率,减小后遗症的发生率,是值得临床推广使用的治疗病毒性脑炎的辅助方法。
Objective To investigate the clinical effect of edaravone injection in viral encephalitis and analyze and evaluate the results. Methods Sixty patients with viral encephalitis were randomly divided into observation group (n = 30) and control group (n = 30). Patients in control group were treated with routine therapy, anciclovir antivirus and symptomatic treatment Fever and other treatment). The observation group was given edaravone on the basis of the control group. The clinical effects of the two methods were compared and analyzed. Results The total effective rate of the control group was 80.0%. The total effective rate of the observation group was 93.3%. The total effective rate of the observation group was significantly higher than that of the control group (P <0.05). Conclusion This study suggests that edaravone injection can treat viral encephalitis, which can effectively improve the cure rate of patients and reduce the incidence of sequelae. It is an adjunct to clinical treatment of viral encephalitis.